Jamie L. Miller, Pharm.D., BCPS, BCPPS, FPPAG

---

Publications & Presentations

41. Miller J L, Oldham M M, Neely S, Medina M. Impact of Transitioning a Senior Seminar Capstone Course from Weekly Classes to an Intensive Hybrid Course. American journal of pharmaceutical education. 2022

42. Johnson P N, Mayes R, Moore E, Neely S, Nguyen A, Miller J L. Ketamine infusions as an adjunct for sedation in critically ill children. Journal of opioid management. 2022; 18 : 57-68

43. Harkin M, Miller J L, Lim S Y, Neely S, Walsh C K, Johnson P N. Conversion From Continuous Infusion Fentanyl to Continuous Infusion Hydromorphone in the Pediatric Intensive Care Unit. The Annals of pharmacotherapy. 2021; 55 : 1439-1446

44. Bobo K S, Cober M P, Eiland L S, Heigham M, King M, Johnson P N, Miller J L, Sierra C M. Key articles and guidelines for the pediatric clinical pharmacist from 2019 and 2020. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2021

45. Moore E, Mayes R, Harkin M, Miller J L, Johnson P N. Extended Duration Ketamine Infusions in Critically Ill Children: A Case Report and Review of the Literature. Journal of pediatric intensive care. 2021; 10 : 221-227

Grants

1. Selenium Pharmacokinetics and Pharmacodynamics of Infants with Intestinal Failure a Prospective Cohort Study. Misc Non-Federal. Start Date: 2025. End Date: 2026.

2. Evaluation of caffeine dosing regimens and the impact of developmental pharmacokinetics in neonates with apnea of prematurity. Misc Non-Federal. Start Date: 2020. End Date: 2021.

3. Characterization of fentanyl metabolic and renal elimination pathways in children less than two years of age. Misc Non-Federal. Start Date: 2018. End Date: 2020.

4. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.

5. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.

Awards and Honors

6. American Society of Health-System Pharmacists. Fellow of American Society of Health-System Pharmacists. Date: 2024.


7. Oklahoma Residency Research Conference. Oklahoma Research Excellence Award (Mentor). Date: 2023.


8. Oklahoma Residency Research Conference. Oklahoma Research Excellence Award (Mentor). Date: 2023.


9. University of Oklahoma Health Sciences Center. President's Associates Presidential Professorship. Date: 2023.


10. Pediatric Pharmacy Association. Christensen Memorial Young Investigator Award Nominee (Resident Mentor). Date: 2022.

Education

1. Degree: PharmD. Southwestern Oklahoma State University. Date: 2006.


2. Degree: BS. Trevecca Nazarene University. Date: 2002.

Administrative Assignments

1. Role: Department Vice-Chair. Scope: Department. Date: 2021.
Read More